Turning social risk into measurable financial performance

Payers increasingly recognize that social risk factors materially influence total cost of care, utilization, and quality performance. Yet for many organizations, social risk data remains siloed, underoperationalized, and inactionable.

On a recent webinar, MedeAnalytics and Socially Determined demonstrated how health plans can integrate member-level social risk data directly into payer analytics workflows, alongside claims, pharmacy, HCCs, and utilization data, to support better capital allocation decisions, defensible ROI, and scalable intervention strategies.

The payer challenge

Traditional payer analytics can identify “which members are sick” but often fail to explain “why some members cost more than others” within clinically similar populations. On average, members spend approximately 60 minutes per year interacting with providers¹, meaning most health-related decision and behaviors are influenced by social and environmental conditions that drive adherence, utilization, and avoidable spend.

For payers, this results in:

• Missed early financial signals within risk pools
• Delayed identification of individual members with rising risk
• Limited ability to link interventions to MLR improvement
• Social determinants of health (SDOH) initiatives perceived as discretionary or compliance-driven rather than strategic ‑driven rather than strategic

What changes when social risk is integrated

When social risk is embedded at the member level within a payer’s analytics infrastructure, new patterns emerge that materially affect financial performance:

• Cost variation becomes visible within the same disease cohorts
• Members likely to progress into high-cost utilization are identified earlier‑cost utilization
• Interventions can be prioritized based on measurable financial impact
• Stacked social risks (e.g., food + transportation) that drive exponential—not linear—cost growth becomes visible at the member level

This reframes SDOH from a population health concept into a risk refinement and spend management lever.

Proof point: Commercial population assessment

One client assessment was conducted using:

• Approximately 450,000 commercially insured members
• Three years of medical and pharmacy claims
• Member level social risk profiles across five domains: food, housing, transportation, financial strain, and health literacy‑level social risk profiles across five domains
• Independent actuarial validation

Key result: A cohort of fewer than 5,000 members (less than 1% of the population) associated with maternal outcomes represented:

• $2.4M–$5.4M in addressable savings
• Up to 200% ROI
• An additional $1.2M in savings with the inclusion of food and housing supports
• Clear intervention pathways with measurable financial value

These findings come from a commercial population, underscoring that the relevance of social risk is not limited to Medicaid or Medicare Advantage members.

Getting started: Opportunity assessment

Instead of conducting traditional pilots, payers begin with an opportunity assessment that enables them to:

• Integrate eligibility, claims, and social risk data rapidly (days to weeks)
• Identify priority cohorts with outsized PMPM impact
• Generate actuarially validated savings estimates
• Establish clear connections between interventions, costs, and expected ROI

The result is an executive-ready business case that supports confident investment decisions before operational dollars are committed. Payers that choose to act on the assessment enter an ongoing partnership that includes validation of the expected results and ROI analysis of the prescribed interventions.

What success looks like for payers

Within 12 months of the partnership, leading payers can expect to:

• Embed social risk into forecasting, stratification, and resource allocation
• Target interventions that measurably reduce avoidable spend
• Improve MLR performance through precision investment
• Transition SDOH from compliance or innovation teams into core payer analytics
• Establish social risk as a repeatable, scalable financial strategy

Bottom line for payer leaders

Social risk is not a side initiative—it is a risk signal.
When integrated with claims and clinical data, social risk enables payers to deploy capital more precisely, intervene earlier, and deliver measurable financial returns.

Learn more and inquire about your own Opportunity Assessment.